WADA Prohibition The World Anti-Doping Agency classifies both peptides as prohibited substances for competitive athletes: Section S2 classification Peptide Hormones, Growth Factors, and Related Substances Prohibited at all times (both in-competition and out-of-competition) No Therapeutic Use Exemptions available not recognized as legitimate medical treatments Performance-enhancing potential acknowledged due to growth hormone secretagogue effects Detection methods under development for anti-doping testing programs WADAs position reflects that these peptides possess clear performance-enhancing properties and lack approved therapeutic applications that would justify medical use exemptions
Danik Martirosyan, PhD Danik Martirosyan, PhD Published Mar 26, 2019 In a recent in vitro study published in the FFHD Journal, a team of scientists led by Richi Nakatake concluded that glutathione may be able to drive downregulation of the expression of inducible nitric oxide synthase
For glucose control, head-to-head trials have shown that oral semaglutide 14mg produces HbA1c reductions comparable to the injectable form at lower doses, making it a clinically meaningful option for many patients with type 2 diabetes whose primary goal is glucose management with cardiovascular protection
Led by Acute Care Nurse Practitioner Cassandra Debenham, who brings over 15 years of intensive care experience, our team combines advanced medical expertise with a personalized, integrative approach to help you live your best life
